The Food and Drug Administration has updated information on the shortage of leucovorin as of January 21, 2009.
- Teva Parenteral Medicines reports a shortage of Leucovorin Calcium Lyophilized Powder for Injection due to “Increase in Demand”.
- Bedford Laboratories reports a shortage of Leucovorin Calcium Solution for Injection and Leucovorin Calcium Lyophilized Powder for Injection due to “Manufacturing Delays.”
- Please call 1-888-TevaUSA for additional information. Teva is manufacturing at full capacity.
- Bedford Customer Service 1-440-232-3320
If you are a physician or patient who is currently experiencing difficulties because of the shortage of leucovorin, C3 needs your input as we work on this problem on behalf of patients. You can email the C3 Director of Research Communication, call the C3 Answer Line at 877-4CRC-111 (877-427-2111), or leave a comment below.